Preventing Muscle Loss After Bariatric Surgery: Protein-Collagen Supplementation and Resistance Exercise

NCT ID: NCT07303543

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-02

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this clinical trial is to investigate the effectiveness of collagen, considered a new approach to prevent muscle mass loss after bariatric surgery, and to demonstrate the relationship between this effect and exercise. The key questions it aims to answer are:

Does whey protein supplementation with collagen combined with resistance exercise prevent muscle mass loss after bariatric surgery? Do whey protein supplementation with collagen combined with resistance exercise affect fat mass after bariatric surgery?

Researchers will compare collagen with whey protein.

The study groups and interventions to be implemented are summarized below:

Group 1: Control Group (CG; n: 10) Whey protein supplementation will be administered Vitamin and mineral supplementation will be administered No resistance exercise will be performed The participants will eat according to bariatric surgery nutrition guidelines and perform physical activities.

Group 2: Whey Protein + Collagen + Exercise Group (WPCEG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

They will begin a resistance exercise program 4 weeks after surgery.

Group 3: Whey Protein + Collagen + No Exercise Group (WPCG; n: 10) Whey protein supplements with collagen will be given. Vitamin and mineral supplements will be given. No resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

Group 4: Whey Protein + Exercise Group (WPEG; n: 10) Whey protein supplements will be given. Vitamin and mineral supplements will be given. Resistance exercise will be performed. They will eat according to bariatric surgery nutrition guidelines and perform physical activities.

A resistance exercise program will begin at 4 weeks post-operatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bariatric surgery is an effective method for treating obesity, but a significant decrease in skeletal muscle mass can be observed in the early postoperative period. This loss of muscle mass can negatively affect physical functions, reduce metabolic rate, and make long-term weight maintenance more difficult. Therefore, developing strategies to prevent muscle loss after bariatric surgery is of great clinical importance.

The use of whey protein to support muscle protein synthesis in the postoperative period is a common practice. In recent years, there has been increased scientific interest in the potential of collagen peptides, especially when used in conjunction with resistance exercise, to contribute to muscle mass preservation. However, studies evaluating the combined effect of collagen supplementation and exercise programs in addition to whey protein in individuals undergoing bariatric surgery are limited.

This clinical study aims to investigate the effectiveness of adding collagen to standard whey protein supplementation and a resistance exercise program in preventing muscle loss. Four different groups will be designed to evaluate the independent and combined effects of collagen and exercise:

1. Group receiving only whey protein,
2. Whey + collagen + exercise group,
3. Whey + collagen but no exercise group,
4. Whey + exercise but no collagen group.

All participants will follow a standard post-bariatric surgery nutrition protocol and receive routine vitamin and mineral supplements. The resistance exercise program will begin four weeks after surgery; it will consist of progressively more intense, supervised exercises targeting large muscle groups. Body composition assessments will be performed at baseline and at specified follow-up weeks. The primary outcome measure is change in skeletal muscle mass; secondary outcome measures are fat mass, functional capacity, and exercise compliance.

This study is expected to contribute to the identification of optimal nutrition and exercise strategies to reduce muscle loss after bariatric surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bariatric Surgery Muscle Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Bariatric Surgery Collagen Resistance exercise Whey protein Muscle loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group (CG)

Whey protein supplementation will be provided. Vitamin and mineral supplementation will be administered. No resistance exercise will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their regular physical activities.

A comparison will be made with the other groups as the control group.

Group Type ACTIVE_COMPARATOR

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Vitamin and Mineral Supplementation

Intervention Type DIETARY_SUPPLEMENT

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Whey Protein + Collagen + Exercise Group (WPCEG)

Collagen-containing whey protein supplementation will be provided. Vitamin and mineral supplementation will be given. Resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities.

They will begin the resistance exercise program in the 4th week after surgery.

Group Type EXPERIMENTAL

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Hydrolyzed Collagen Supplement

Intervention Type DIETARY_SUPPLEMENT

Oral hydrolyzed collagen supplement provided daily in combination with whey protein.

Vitamin and Mineral Supplementation

Intervention Type DIETARY_SUPPLEMENT

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Resistance Exercise Program

Intervention Type BEHAVIORAL

Structured resistance exercise program initiated at postoperative week 4, supervised, 3 times per week.

Whey Protein + Collagen + Non-Exercise Group (WPCG)

Collagen-containing whey protein supplementation will be provided. Vitamin and mineral supplementation will be administered. No resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities.

Group Type EXPERIMENTAL

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Vitamin and Mineral Supplementation

Intervention Type DIETARY_SUPPLEMENT

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Whey Protein + Exercise Group (WPEG)

Whey protein supplementation will be provided. Vitamin and mineral supplementation will be given. Resistance exercises will be performed. Participants will follow bariatric surgery nutrition guidelines and maintain their physical activities.

They will begin the resistance exercise program in the 4th week after surgery.

Group Type EXPERIMENTAL

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Vitamin and Mineral Supplementation

Intervention Type DIETARY_SUPPLEMENT

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Resistance Exercise Program

Intervention Type BEHAVIORAL

Structured resistance exercise program initiated at postoperative week 4, supervised, 3 times per week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whey protein supplement

Oral whey protein supplement provided daily according to bariatric surgery nutrition protocol.

Intervention Type DIETARY_SUPPLEMENT

Hydrolyzed Collagen Supplement

Oral hydrolyzed collagen supplement provided daily in combination with whey protein.

Intervention Type DIETARY_SUPPLEMENT

Vitamin and Mineral Supplementation

Routine vitamin and mineral supplementation according to bariatric surgery follow-up protocol.

Intervention Type DIETARY_SUPPLEMENT

Resistance Exercise Program

Structured resistance exercise program initiated at postoperative week 4, supervised, 3 times per week.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being between 20-50 years old
* Body mass index; 35 ≤ BMI\< 60 kg/m2
* Not being pregnant
* Not being addicted to alcohol and drugs
* Not having entered menopause
* No exercise restrictions

Exclusion Criteria

* Having at least one of the following inflammatory bowel diseases, upper gastrointestinal bleeding, advanced psychiatric diseases, cancer, and kidney failure.
* using statins
* be pregnant
* Being addicted to alcohol and drugs
* to have entered menopause
* Having exercise restrictions
* Becoming a professional athlete
* Having done more than 60 minutes of regular and structured exercise per week in the last year
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medipol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rüken Aslınur Samanci

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Halit E Taşkın, Dr.

Role: PRINCIPAL_INVESTIGATOR

Cerrahpaşa Faculty of Medicine, General Surgery

Nihal Z Erdem, PhD

Role: PRINCIPAL_INVESTIGATOR

Istanbul Medipol University, Nutrition and Dietetics

Bürke Köksalan, PhD

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Medipol University

Istanbul, Fatih, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rüken A Samancı, Msc

Role: CONTACT

Phone: +90 543 939 15 94

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rüken A Samancı, Msc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-66291034-772.02-3053

Identifier Type: -

Identifier Source: org_study_id